Andrew Manford

Andrew Manford started their work experience as a Postdoc at UC Berkeley in March 2014. Andrew worked in this role until November 2022. In November 2022, Andrew joined Lyterian Therapeutics as a Senior Scientist, where they are currently employed.

Andrew Manford has a strong educational background in the field of biochemistry and molecular biology. From 2002 to 2006, they pursued their Bachelor of Science (BS) degree at the University of California, Davis. Following this, they enrolled at Cornell University, where they completed their Doctor of Philosophy (PhD) in Biochemistry, Molecular and Cell Biology between 2007 and 2014.